| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_73afc696dd3f4cdb9e9b5c42aebac4fb |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate |
2014-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2019-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c34f394390b918335dcb648ce2605b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbbaeab36f3d18a6759c12a6fa71cc1d |
| publicationDate |
2019-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-10335366-B2 |
| titleOfInvention |
Risperidone or paliperidone implant formulation |
| abstract |
The present invention is directed to an injectable intramuscular depot composition suitable for forming an in situ solid implant in a body, comprising a drug which is risperidone and/or paliperidone or any pharmaceutically acceptable salt thereof in any combination, a biocompatible copolymer based on lactic and glycolic acid having a monomer ratio of lactic to glycolic acid of about 50:50 and a DMSO solvent, wherein the composition releases the drug with an immediate onset of action and continuously for at least 4 weeks and wherein the composition has a pharmacokinetic profile in vivo that makes it suitable to be administered each 4 weeks or even longer periods. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021077380-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10912735-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023046731-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11173110-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022192972-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11759416-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022280417-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10881605-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11752092-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11752093-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11752094-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11013683-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11007139-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022133623-A1 |
| priorityDate |
2010-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |